Clinical Trial Update: Survivin Urine mRNA Assay Risk of Bladder Cancer Study

View source ↗

Summary

This entry notes the completed clinical trial evaluating the survivin urine mRNA assay as a biomarker for assessing bladder cancer risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Survivin Urine mRNA Assay

Snippet

Sponsor: Fujirebio Diagnostics, Inc. | Conditions: Bladder Cancer | Status: COMPLETED